PubMed=9241074; DOI=10.1002/(SICI)1097-0142(19970801)80:3<401::AID-CNCR8>3.0.CO;2-U
Zeinab Abdel-Wahab, Christina Weltz, Dina Hester, Nancy Pickett, Carol Vervaert, Jack R. Barber, Douglas J. Jolly, Hilliard Foster Seigler;
A phase I clinical trial of immunotherapy with interferon-gamma gene-modified autologous melanoma cells: monitoring the humoral immune response.
Cancer 80:401-412(1997)

PubMed=11520076; DOI=10.1006/cimm.2001.1809
Rahima Zennadi, Zeinab Abdel-Wahab, Hilliard Foster Seigler, Timothy L. Darrow;
Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells.
Cell. Immunol. 210:96-105(2001)

PubMed=19147755; DOI=10.1158/1078-0432.CCR-08-1916
Christina K. Augustine, Jin Soo Yoo, Anil Potti, Yasunori Yoshimoto, Patricia A. Zipfel, Henry Seth Friedman, Joseph R. Nevins, Francis Ali-Osman, Douglas Scott Tyler;
Genomic and molecular profiling predicts response to temozolomide in melanoma.
Clin. Cancer Res. 15:502-510(2009)